Skip to main content

Table 3 Pearson correlation coefficients for the scores of the PTSD checklist (at months 1, 6 and, 12), the hospital anxiety and depression scale (Months 3, 6, 9 and 12), and the SF-36 health survey (Months 1 and 12)

From: Ambulatory Medical Assistance - After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy

PTSD (M0)

PTSD (M6)

PTSD (M12)

HADA (M3)

HADA (M6)

HADA (M9)

HADA (M12)

HADD (M3)

HADD (M6)

HADD (M9)

HADD (M12)

SF36 MCS (M0)

SF36-PCS (M0)

SF36-MCS (M12)

SF36-PCS (M12)

 

1

0.79649

0.73146

0.56455

0.55338

0.53787

0.59773

0.44034

0.39448

0.38274

0.47341

−0.51828

−0.41293

−0.59287

−0.54638

PTSD

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

(M0)

 

1

0.79187

0.58923

0.6597

0.65753

0.7029

0.41921

0.47819

0.48008

0.49995

−0.5599

−0.4472

−0.64859

−0.56404

PTSD

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.00016

<.0001

<.0001

(M6)

  

1

0.45231

0.52977

0.59971

0.64537

0.33995

0.39253

0.46842

0.54995

−0.38771

−0.30926

−0.69486

−0.54733

PTSD

<.0001

<.0001

<.0001

<.0001

0.0004

<.0001

<.0001

<.0001

<.0001

0.0013

<.0001

<.0001

(M12)

   

1

0.65131

0.70539

0.62431

0.42708

0.30713

0.29832

0.34666

−0.3969

−0.36314

−0.45017

−0.37952

HADA

<.0001

<.0001

<.0001

<.0001

0.0009

0.0015

0.0002

<.0001

<.0001

<.0001

<.0001

(M3)

    

1

0.74176

0.71154

0.40855

0.48015

0.47148

0.43145

−0.38351

−0.4053

−0.43999

−0.40748

HADA

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

(M6)

     

1

0.77938

0.47043

0.44302

0.55754

0.49862

−0.37517

−0.36301

−0.49752

−0.43972

HADA

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

(M9)

      

1

0.38733

0.49511

0.51986

0.55888

−0.48623

−0.43266

−0.51551

−0.46204

HADA

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

(M12)

       

1

0.64098

0.58671

0.56799

−0.48358

−0.39613

−0.42135

−0.39067

HADD

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

(M3)

        

1

0.57086

0.58342

−0.40282

−0.36483

−0.41359

−0.39385

HADD

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

(M6)

         

1

0.73002

−0.31758

−0.31682

−0.5145

−0.45989

HADD

<.0001

0.0007

0.0007

<.0001

<.0001

(M9)

          

1

−0.39559

−0.37602

−0.6048

−0.49074

HADD

<.0001

<.0001

<.0001

<.0001

(M12)

           

1

0.78154

0.49547

0.47986

SF36 MCS

<.0001

<.0001

<.0001

(M0)

            

1

0.46939

0.64959

SF36-PCS

<.0001

<.0001

(M0)

             

1

0.80799

SF36-MCS

<.0001

(M12)

              

1

SF36-PCS (M12)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us